80
Participants
Start Date
April 15, 2021
Primary Completion Date
September 20, 2021
Study Completion Date
December 15, 2021
Intranasal oxytocin
Each subject will be assigned to intranasal administration of oxytocin (24 IU).
intranasal placebo
Each subject will be assigned to intranasal placebo.
University of Electronic Science and Technology of China (UESTC), Chengdu
University of Electronic Science and Technology of China
OTHER